Cara Therapeutics (NQ: CARA )

18.62 USD -0.64 (-3.32%)

Streaming Delayed Price Updated: 11:34 AM EST, Feb 26, 2021 Add to My Watchlist

Price and Volume

Volume	103,900
Open	19.66
Bid (Size)	18.62 (1)
Ask (Size)	18.73 (4)
Prev. Close	19.26
Today's Range	18.35 - 19.85
52wk Range	8.880 - 22.60
Shares Outstanding	33,874,770
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Cara Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results

February 25, 2021

Cara Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

February 18, 2021

Performance

YTD	+23.56%	+23.56%
1 Month	-2.92%	-2.92%
3 Month	+24.55%	+24.55%
6 Month	+23.23%	+23.23%
1 Year	+17.40%	+17.40%

More News

Cara Initiates Phase 2 Trial of Oral KORSUVA™ for the Treatment of Pruritus in Patients with Notalgia Paresthetica

January 11, 2021

Cara Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

January 06, 2021

Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KORSUVA™ Injection in Hemodialysis Patients with Moderate-to-Severe Pruritus

December 28, 2020

First Week of April 16th Options Trading For Cara Therapeutics

February 24, 2021

Preview: Cara Therapeutics's Earnings

February 24, 2021

Notable Tuesday Option Activity: UNH, CARA, IIPR

February 23, 2021

Cara Therapeutics Inc (CARA) Q4 2020 Earnings Call Transcript

Today 8:01 EST

Implied XPH Analyst Target Price: $68

February 17, 2021

Should you invest in Cara Therapeutics, Applied Materials, Caterpillar, Roku, or Alibaba?

February 16, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Market Watch

Cara Therapeutics (NQ: CARA )

Price and Volume

Top News

Performance

More News